Measles seroepidemiology among adolescents and young adults: response to revaccination
(East. Mediterr. health j).
em Inglês
| WHO IRIS
| ID: who-117121
Biblioteca responsável:
CH1.1
ABSTRACT
We evaluated the seroprevalence of measles antibody and response to measles re-immunization in 590 previously vaccinated adolescents and young adults; 263 were seronegative. To differentiate between primary and secondary vaccine failure, anti- measles IgM and IgG titres were assessed again 2- 4 weeks after revaccination in 144 [105 seronegative, 39 seropositive] individuals 75 seronegative participants responded to revaccination anamnestically [P < 0.001] and developed immunity 11 also showed IgM response [probably primary vaccine failure immunity]; 38 seropositive participants, remained seroprotected without significant increase in antibody titre [P = 0.577]. Primary vaccine failure was 4.7%; secondary vaccine failure was 27.1%. After revaccination, 87.3% were seroprotected
Texto completo:
Disponível
Coleções:
Bases de dados de organismos internacionais
Base de dados:
WHO IRIS
Assunto principal:
Testes Sorológicos
/
Vacina contra Sarampo
/
Monitorização Imunológica
/
Sarampo
Idioma:
Inglês
Revista:
East. Mediterr. health j
Ano de publicação:
2006